Ursula Matulonis, MD

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 Dana Farber/Partners Cancer CareBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 3
- CONDITIONS3
- INTERVENTIONS5
- SINCE2008

Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod
August 2008 - December 2011

Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian Fallopian Tube or Primary Peritoneal Cancer
September 2008 - December 2011

Study of Oral ENMD-2076 Administered to Patients With Ovarian Cancer
April 2010 - December 2011
Ovarian Neoplasms
Peritoneal Neoplasms
Fallopian Tube Neoplasms
Gm-Csf
Dendritic Cell/Tumor Fusion Vaccine
Imiquimod
Enmd-2076
Tumor Collection



